L-BMAA hydrochlorideNeurotoxic amino acid CAS# 16012-55-8 |
2D Structure
- BMS-708163 (Avagacestat)
Catalog No.:BCC2104
CAS No.:1146699-66-2
- DAPT (GSI-IX)
Catalog No.:BCC3618
CAS No.:208255-80-5
- YO-01027 (Dibenzazepine, DBZ)
Catalog No.:BCC2100
CAS No.:209984-56-5
- Semagacestat (LY450139)
Catalog No.:BCC3610
CAS No.:425386-60-3
- Flurizan
Catalog No.:BCC2342
CAS No.:51543-40-9
- E 2012
Catalog No.:BCC1540
CAS No.:870843-42-8
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 16012-55-8 | SDF | Download SDF |
PubChem ID | 51358333 | Appearance | Powder |
Formula | C4H11ClN2O2 | M.Wt | 154.6 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble to 60 mM in water | ||
Chemical Name | (2S)-2-amino-3-(methylamino)propanoic acid;hydrochloride | ||
SMILES | CNCC(C(=O)O)N.Cl | ||
Standard InChIKey | VDXYGASOGLSIDM-DFWYDOINSA-N | ||
Standard InChI | InChI=1S/C4H10N2O2.ClH/c1-6-2-3(5)4(7)8;/h3,6H,2,5H2,1H3,(H,7,8);1H/t3-;/m0./s1 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Description | Neurotoxic glutamate agonist originally isolated from Cycas circinalis. Implicated in the pathogenesis of amyotrophic lateral sclerosis-Parkinsonism-dementia complex of Guam (Guam ALS-PD). |
L-BMAA hydrochloride Dilution Calculator
L-BMAA hydrochloride Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 6.4683 mL | 32.3415 mL | 64.6831 mL | 129.3661 mL | 161.7076 mL |
5 mM | 1.2937 mL | 6.4683 mL | 12.9366 mL | 25.8732 mL | 32.3415 mL |
10 mM | 0.6468 mL | 3.2342 mL | 6.4683 mL | 12.9366 mL | 16.1708 mL |
50 mM | 0.1294 mL | 0.6468 mL | 1.2937 mL | 2.5873 mL | 3.2342 mL |
100 mM | 0.0647 mL | 0.3234 mL | 0.6468 mL | 1.2937 mL | 1.6171 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- 2-Iminopiperidine hydrochloride
Catalog No.:BCC6862
CAS No.:16011-96-4
- SCH 58261
Catalog No.:BCC7306
CAS No.:160098-96-4
- Cryptofolione
Catalog No.:BCN7197
CAS No.:160098-78-2
- Huwentoxin XVI
Catalog No.:BCC8041
CAS No.:1600543-88-1
- Sambutoxin
Catalog No.:BCN1709
CAS No.:160047-56-3
- Antibiotic AB 4063B
Catalog No.:BCN1827
CAS No.:160041-33-8
- Iniparib (BSI-201)
Catalog No.:BCC2208
CAS No.:160003-66-7
- Nelfinavir Mesylate
Catalog No.:BCC1794
CAS No.:159989-65-8
- Nelfinavir
Catalog No.:BCC4138
CAS No.:159989-64-7
- NIBR189
Catalog No.:BCC8056
CAS No.:1599432-08-2
- 3,5-Di-O-caffeoylquinic acid methyl ester
Catalog No.:BCN6491
CAS No.:159934-13-1
- Mc-Val-Cit-PABC-PNP
Catalog No.:BCC4028
CAS No.:159857-81-5
- 7-Chloro-1,2,3,4-tetrahydrobenzo[b]azepin-5-one
Catalog No.:BCC8779
CAS No.:160129-45-3
- BIM 23127
Catalog No.:BCC5822
CAS No.:160161-61-5
- SR 11302
Catalog No.:BCC3607
CAS No.:160162-42-5
- 14-Deoxy-11-hydroxyandrographolide
Catalog No.:BCN4702
CAS No.:160242-09-1
- SB 205384
Catalog No.:BCC7095
CAS No.:160296-13-9
- 8-Hydroxybergapten
Catalog No.:BCN2732
CAS No.:1603-47-0
- L-368,899 hydrochloride
Catalog No.:BCC7438
CAS No.:160312-62-9
- Bisdehydroneotuberostemonine
Catalog No.:BCN7072
CAS No.:160333-27-7
- X-NeuNAc
Catalog No.:BCC2063
CAS No.:160369-85-7
- 3',5,5',7-Tetrahydroxyflavanone
Catalog No.:BCN1710
CAS No.:160436-10-2
- 30-Oxopseudotaraxasterol
Catalog No.:BCN7135
CAS No.:160481-71-0
- THZ1
Catalog No.:BCC4005
CAS No.:1604810-83-4
Neurotoxicity of beta-N-methylamino-L-alanine (BMAA) and beta-N-oxalylamino-L-alanine (BOAA) on cultured cortical neurons.[Pubmed:2551452]
Brain Res. 1989 Sep 11;497(1):64-71.
Recent studies have implicated the ingestion of the structurally related plant excitotoxins, beta-N-methylamino-L-alanine (BMAA), and beta-N-oxalylamino-L-alanine (BOAA), in the pathogenesis of two human motor system diseases, the amyotrophic lateral sclerosis-Parkinsonism-dementia complex of Guam (Guam ALS-PD), and lathyrism, respectively. We have investigated the toxicity of these amino acids on cultured mouse cortical neurons in the presence of physiological concentrations of bicarbonate (a required toxic cofactor for BMAA neurotoxicity). A 24 h exposure to 10 microM - 3 mM BMAA, or to 300 nM - 100 microM BOAA, induced, concentration-dependent neuronal degeneration without glial damage; the neurotoxic EC50 for BMAA was about 1 mM, and the EC50 for BOAA was about 20 microM. At high concentrations, both compounds destroyed essentially the entire neuronal population. Neurotoxicity also depended on exposure duration, with reduced injury at an exposure time of 1 h, and increased injury at an exposure time of 3 days. Despite the fact that ingestion of BMAA and BOAA both lead to motor system damage, previous studies have suggested that the two excitotoxins act primarily on different glutamate receptor subtypes: BMAA on N-methyl-D-aspartate (NMDA) receptors, and BOAA on non-NMDA receptors. Consistent with these studies, the neurotoxicity of high concentrations of BMAA was substantially attenuated by 1 mM D-amino-5-phosphonovalerate (D-APV), whereas BOAA neurotoxicity was less sensitive to D-APV but was attenuated by 2 mM kynurenate.(ABSTRACT TRUNCATED AT 250 WORDS)